This site is intended for healthcare professionals

CPD
CPD
Pro
Pro
Sign in
Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Laboratory features

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • peripheral blood:
    • the white count is raised, usually > 30 x 10^9 / litre, commonly, 100-250 x 10^9 / litre
    • differential:
      • the myeloid series is left-shifted with mature forms dominating
      • granulocytes especially neutrophils and myelocytes, greatly increased
      • basophilia and eosinophilia is common (1)
      • low percentage of blasts
    • red cells - anaemia in later stages, normocytic, normochromic
  • platelets - often normal, may be increased or decreased

  • bone marrow:
    • hypercellular with prominent granulocytic hyperplasia
    • megakaryocytic numbers often raised
    • high proportion of blasts suggests transformation

  • trephine biopsy - useful to assess degree of fibrosis and loss of marrow fat spaces

  • Philadelphia chromosome - often detected in peripheral blood or bone marrow

  • neutrophil alkaline phosphatase score is low providing evidence of qualitative abnormalities in neutrophils

  • serum vitamin B12 is high due to increased secretion of transcobalamin III

  • serum uric acid and alkaline phosphatase - often raised

Reference:

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.